中美(河南)荷美尔肿瘤研究院

2022年科研论文发表情况

发布时间:2022-04-01
浏览次数:
序号发表论文年度月份论文题目中科院分区JCR分区期刊(SCI影响因子,2020年)
12022/1Chuntian Huang #, Ruijuan Du #, Xuechao Jia, Kangdong Liu, Yan Qiao, Qiong Wu, Ning Yao, Lu Yang, Liting Zhou, Xuejiao Liu, Pu Xiang, Mingxia Xin, Yan Wang, Xiaojie Chen, Dong Joon Kim, Zigang Dong, Xiang Li. CDK15 promotes colorectal cancer progression via phosphorylating PAK4 and regulating β-catenin/ MEK-ERK signaling pathway. Cell Death Differ. 2021 Jul 14.1区1区15.828
22022/1Xueli Tian, Tingxuan Gu, Mee-Hyun Lee, Zigang Dong. Challenge and countermeasures for EGFR targeted therapy in non-small cell lung cancer. Biochim Biophys Acta Rev Cancer
. 2022 Jan;1877(1):188645.
2区2区10.68
32022/2Qiong Wu #, Fangfang Liu #, Mengmeng Ge, Kyle Vaughn Laster, Lixiao Wei, Ruijuan Du, Ming Jiang, Jing Zhang, Yafei Zhi, Guoguo Jin, Simin Zhao, Dong Joon Kim, Zigang Dong, Kangdong Liu. BRD4 drives esophageal squamous cell carcinoma growth by promoting RCC2 expression. Oncogene. 2022 Jan;41(3):347-360.1区1区9.867
42022/2Zhuo Bao #, Ang Li #, Xuebo Lu, Zitong Wang, Yin Yu, Wenjie Wu, Lili Zhao, Bo Li, Xiangyu Wu, Kyle Vaughn Laster, Chengjuan Zhang, Yanan Jiang, Zigang Dong, Kangdong Liu. Oxethazaine inhibits esophageal squamous cell carcinoma proliferation and metastasis by targeting aurora kinase A. Cell Death&Disease. 2022 Feb 25;13(2):189.2区1区8.469
52022/3Faisal Aziz, Abhijit Chakraborty, Kangdong Liu, Tianshun Zhang, Xiang Li, Ruijuan Du, Josh Monts, Gang Xu, Yonghan Li, Ruihua Bai, Zigang Dong. Gastric tumorigenesis induced by combining Helicobacter pylori infection and chronic alcohol through IL-10 inhibition. Carcinogenesis. 2022 Mar 24;43(2):126-139.2区1区4.944
62022/2Xiangyu Wang, Xiaomeng Xie, Yuanyuan Zhang, Fayang Ma, Mengjun Pang, Kyle Vaughn Laster, Xiang Li, Kangdong Liu, Zigang Dong, Dong Joon Kim. Hippocalcin-like 1 is a key regulator of LDHA activation that promotes the growth of non-small cell lung carcinoma. Cell Oncol (Dordr). 2022 Feb;45(1):179-191. 2区1区6.73
72022/3Qian Luo, Ruijuan Du, Wenting Liu, Guojing Huang, Zigang Dong, Xiang Li. PI3K/Akt/mTOR Signaling Pathway: Role in Esophageal Squamous Cell Carcinoma, Regulatory Mechanisms and Opportunities for Targeted Therapy. Front Oncol. 2022 Mar 22;12:852383. 2区2区5.738
82022/10Ning Lu#, Tingxuan Gu#, Xueli Tian, Simin Zhao, Guoguo Jin, Fredimoses Mangaladoss, Yan Qiao, Kangdong Liu, Ran Zhao, Zigang Dong, Acetylshikonin inhibits inflammatory responses and Papain-like protease activity in murine model of COVID-19. Signal Transduct Target Ther
. 2022 Oct 27;7(1):371. 
1区1区38.104
92022/9Jiutao Wang, Ning Yao, Yamei Hu, Mingjuan Lei, Meixian Wang, Lu Yang, Satyananda Patel, Xiang Li, Kangdong Liu, Zigang Dong. PHLDA1 promotes glioblastoma cell growth via sustaining the activation state of Ras. Cell Mol Life Sci. 2022 Sep 15;79(10):520. 2区1区9.207
102022/10Yunfeng Gao #, Ming Jiang #, Fangqin Guo, Xuejiao Liu, Qi Zhang, Sen Yang, Yiu To Yeung, Ran Yang, Keke Wang, Qiong Wu, Dandan Zhang, Chengjuan Zhang, Kyle Vaughn Laster, Mengmeng Ge, Wenna Nie, Kangdong Liu, Zigang Dong. A novel lncRNA MTAR1 promotes cancer development through IGF2BPs mediated post-transcriptional regulation of c-MYC. Oncogene. 2022 Oct;41(42):4736-4753.1区1区8.756
112022/4Wei Y, Wu W, Jiang Y, Zhou H, Yu Y, Zhao L, Wu X, Lu X, Yuan Q, Wang Z, Dong Z, He L, Zhao J, Liu K. Nuplazid suppresses esophageal squamous cell carcinoma growth in vitro and in vivo by targeting PAK4. Br J Cancer. 2022 Apr;126(7):1037-1046. doi: 10.1038/s41416-021-01651-z. Epub 2021 Dec 15.1区1区9.075
122022/9Fayang Ma, Kyle Laster, Zigang Dong. The comparison of cancer gene mutation frequencies in Chinese and U.S. patient populations. Nat Commun. 2022 Sep 26;13(1):5651.1区1区17.694
132022/5Fayang Ma, Fangfang Liu, Wenna Nie, Kyle Laster, Xueli Tian, Bingbing Lu, Zushi Geng, Ruihua Bai, Dong Joon Kim, Kangdong Liu, Zigang Dong. 3,3'-Diindolylmethane plus Eflornithine suppress DNA Replication and Cell Cycle in Esophageal Squamous Cell Carcinoma in vivo. J Cancer. 2022 May 16;13(8):2607-2619.2区2区4.478
142022/9Ning Yang #, Xuebo Lu #, Yanan Jiang #, Lili Zhao, Donghao Wang, Yaxing Wei, Yin Yu, Myoung Ok Kim, Kyle Vaughn Laster, Xin Li, Baoyin Yuan, Zigang Dong, Kangdong Liu. Arbidol inhibits human esophageal squamous cell carcinoma growth in vitro and in vivo through suppressing ataxia telangiectasia and Rad3-related protein kinase. Elife. 2022 Sep 9;11:e73953.1区1区8.713
152022/7Faisal Aziz, Xiang Li, Abhijit Chakraborty, Yaqiu Zheng, Mingxia Xin, Kangdong Liu, Zigang Dong. Ubiquitination of ADRα1d/SerpinA1 complex stimulates hypoxia to induce gastric tumorigenesis with a combination of Helicobacter pylori and chronic stress through IL-1α. Gastric Cancer. 2022 Jul;25(4):726-7402区1区7.701
162022/11Fanxiang Yin, Ran Zhao, Dhilli Rao Gorja, Xiaorong Fu, Ning Lu, Hai Huang, Beibei Xu, Hanyong Chen, Jung-Hyun Shim, Kangdong Liu, Zhi Li, Kyle Vaughn Laster, Zigang Dong, Mee-Hyun Lee. Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo. Acta Pharm Sin B. 2022 Nov;12(11):4122-4137.1区1区14.903
172022/10Xueli Tian #, Rui Wang, Tingxuan Gu, Fayang Ma, Kyle Vaughn Laster, Xiang Li, Kangdong Liu, Mee-Hyun Lee, Zigang Dong. Costunolide is a dual inhibitor of MEK1 and AKT1/2 that overcomes osimertinib resistance in lung cancer. Mol Cancer
. 2022 Oct 6;21(1):193.
1区1区41.444
182022/1Pang, Mengjun et al. “Ethyl Ferulate Suppresses Esophageal Squamous Cell Carcinoma Tumor Growth Through Inhibiting the mTOR Signaling Pathway.” Frontiers in oncology vol. 11 780011. 28 Jan. 2022, doi:10.3389/fonc.2021.7800113区3区4.7
192022/12Zhou, Yubing et al. “Repurposed benzydamine targeting CDK2 suppresses the growth of esophageal squamous cell carcinoma.” Frontiers of medicine vol. 17,2 (2023): 290-303.3区3区8.1
202022/3Ruijie Xu, Yongheng Yan, Xu Zheng, Hao Zhang, Wei Chen, Haitao Li, Zigang Dong. Aspirin suppresses breast cancer metastasis to lung by targeting anoikis resistance.Carcinogenesis
. 2022 Mar 24;43(2):104-114.
2区1区4.944
212022/11Xiaojie Chen, Long-Fei Mao, Siqi Tian, Xueli Tian, Xueqiong Meng, Mu-Kuo Wang, Weifeng Xu, Yue-Ming Li, Kangdong Liu Zigang Dong, Icotinib derivatives as tyrosine kinase inhibitors with anti-esophageal squamous carcinoma activity. Front Pharmacol. 2022 Nov 16;13:1028692.2区2区5.988
222023/1Yang Yang, Xiaoli Zheng, Peizan Ni, Dingjie Li, Qinfu Dan, Xiaohui Wang, Yunhan Wang, Yanan Sun, Kangdong Liu, Zigang Dong, Hong Ge. Targeting the STAT5A/IDO1 axis overcomes radioresistance and reverses the immunosuppressive tumor microenvironment in NSCLC.2区2区5.884
232022/5Haibo Zhang, Jun-Koo Yi, Hai Huang, Sijun Park, Wookbong Kwon, Eungyung Kim, Soyoung Jang, Si-Yong Kim, Seong-Kyoon Choi, Duhak Yoon, Sung-Hyun Kim, Kangdong Liu, Zigang Dong, Zae Young Ryoo, Myoung Ok Kim. 20 (S)-ginsenoside Rh2 inhibits colorectal cancer cell growth by suppressing the Axl signaling pathway in vitro and in vivo. J Ginseng Res. 2022 May;46(3):396-407.3区2区5.735
242022/12Zhang, Yangyang et al. “DNA Aptamer Selected against Esophageal Squamous Cell Carcinoma for Tissue Imaging and Targeted Therapy with Integrin β1 as a Molecular Target.” Analytical chemistry vol. 94,49 (2022): 17212-17222.1区1区7.4
252022/11Agboyibor, Clement et al. “Epigenetic compounds targeting pharmacological target lysine specific demethylase 1 and its impact on immunotherapy, chemotherapy and radiotherapy for treatment of tumor recurrence and resistance.” Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie vol. 157 (2023): 113934.2区2区7.5
262022/10Lee, Jin-Young et al. “Picropodophyllotoxin Inhibits Cell Growth and Induces Apoptosis in Gefitinib-Resistant Non-Small Lung Cancer Cells by Dual-Targeting EGFR and MET.” Biomolecules & therapeutics vol. 31,2 (2023): 200-209.3区3区3.7
272022/8Kwak, Ah-Won et al. “Isolinderalactone sensitizes oxaliplatin-resistance colorectal cancer cells through JNK/p38 MAPK signaling pathways.” Phytomedicine : international journal of phytotherapy and phytopharmacology vol. 105 (2022): 154383.1区1区7.9
282022/7Wang, Zitong et al. “Tegaserod Maleate Suppresses the Growth of Gastric Cancer In Vivo and In Vitro by Targeting MEK1/2.” Cancers vol. 14,15 3592. 23 Jul. 20222区2区5.2
292022/6Dong, Jianshu et al. “A comprehensive comparative study on LSD1 in different cancers and tumor specific LSD1 inhibitors.” European journal of medicinal chemistry vol. 240 (2022): 114564. 2区2区6.7
302022/6Xie, Zhenliang et al. “Applications and Achievements of Single-Cell Sequencing in Gastrointestinal Cancer.” Frontiers in oncology vol. 12 905571. 16 Jun. 20223区3区4.7
312022/5Zheng, Qianqian et al. “Two human monoclonal SARS-CoV-2 antibodies that maintain neutralizing potency against the SARS-CoV-2 Omicron BA.1 and BA.2 variants.” Genes & diseases vol. 10,3 (2023): 664-667.2区2区6.8
322022/4Zhou, Wenping et al. “MiRNA-363-3p/DUSP10/JNK axis mediates chemoresistance by enhancing DNA damage repair in diffuse large B-cell lymphoma.” Leukemia vol. 36,7 (2022): 1861-1869. 1区1区11.4
332022/2Ge, Zhenying et al. “The phosphatase of regenerating liver-3 protein (PRL-3) promotes glioma cell invasiveness by interacting with β3 -tubulin.” Bioengineered vol. 13,2 (2022): 4112-4121.4区4区4.9
342022/1Hussain, Shujaat et al. “F-box only protein 9 and its role in cancer.” Molecular biology reports vol. 49,2 (2022): 1537-1544.4区4区2.8
352022/1Park, Kyung-Ho et al. “Licochalcone H Induces Cell Cycle Arrest and Apoptosis in Human Skin Cancer Cells by Modulating JAK2/STAT3 Signaling.” Biomolecules & therapeutics vol. 30,1 (2022): 72-79.3区3区3.7
362022/1Wei, Chen et al. “Characterization of gastric cancer stem-like molecular features, immune and pharmacogenomic landscapes.” Briefings in bioinformatics vol. 23,1 (2022): bbab386.2区2区9.5
372022/10Hwang, Sun-Young et al. “Preclinical activities of Cassia tora Linn against aging-related diseases.” Expert reviews in molecular medicine vol. 24 e43. 25 Oct. 20222区2区6.2
382022/8Li Y, Feng J, Zhao C, Meng L, Shi S, Liu K, Ma J. A new strategy in molecular typing: the accuracy of an NGS panel for the molecular classification of endometrial cancers. Ann Transl Med. 2022 Aug;10(16):870. doi: 10.21037/atm-22-3446. PMID: 36111057; PMCID: PMC9469165.2区2区7.2